_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer-preview-1.jpg "PARPi olaparib for the targeted treatment of metastatic prostate cancer from olaparib prostate cancer results Video Screenshot Preview 1")
Gallery_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer-preview-3.jpg "PARPi olaparib for the targeted treatment of metastatic prostate cancer from olaparib prostate cancer results Video Screenshot Preview 3")
Gallery_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer-preview-hqdefault.jpg "PARPi olaparib for the targeted treatment of metastatic prostate cancer from olaparib prostate cancer results Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 49 seconds
👁 View: 214 times
Play Audio:👁 View: 214 times
Description:
Vall d'Hebron Institute of Oncology - VHIO
Vall d'Hebron Institute of Oncology - VHIO
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_what-is-sepsis.webp "In Australia, the burden of death from sepsis is greater than the annual national road toll and kills more than breast, prostate and colo-rectal cancer.")
_parp-inhibitors-for-metastatic-hormone-sensitive-prostate-cancer.webp "VJOncology")
_parp-inhibitors-for-prostate-cancer.webp "Cleveland Clinic")
_prostate-cancer-highlights-from-esmo-2022.webp "Dana-Farber Cancer Institute")
_olaparib-and-keytruda-for-advanced-prostate-cancer-124-124-learn-about-clinical-trials.webp "Prostate Cancer Research Institute")
⏲ 5 minutes 14 seconds 👁 1.6K
_exciting-times-for-hormone-sensitive-prostate-cancer-treatment.webp "VJOncology")
_profound-olaparib-for-hrr-mcrpc.webp "OncLiveTV")
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.webp "VJOncology")
_what-is-sepsis.jpg)
_parp-inhibitors-for-metastatic-hormone-sensitive-prostate-cancer.jpg)
_parp-inhibitors-for-prostate-cancer.jpg)
_prostate-cancer-highlights-from-esmo-2022.jpg)
_olaparib-and-keytruda-for-advanced-prostate-cancer-124-124-learn-about-clinical-trials.jpg)
_exciting-times-for-hormone-sensitive-prostate-cancer-treatment.jpg)
_profound-olaparib-for-hrr-mcrpc.jpg)
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.jpg)
![[+]](/images/menu.gif){kind=small}